Health and Fitness Health and Fitness
Wed, September 22, 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
Alcon Launches TobraDex® ST Suspension
[ Wed, Sep 22nd 2010 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Arena Pharmaceuticals, Inc.
[ Wed, Sep 22nd 2010 ] - Market Wire
Data Published Today Reveal That Novel Oral Thera .. Positive Response in Rheumatoid Arthritis Patient
[ Wed, Sep 22nd 2010 ] - Market Wire
AMED Restructures 39 Agencies, Reduces Planned Start-ups
[ Wed, Sep 22nd 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Proposed Public Offering of Convertible Senior Subordinated Notes
[ Wed, Sep 22nd 2010 ] - Market Wire
Alnylam Announces Update on its Board of Directors
[ Wed, Sep 22nd 2010 ] - Market Wire
ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGE .. É(R) STENT IN SMALL VESSELS AND LONG LESIONS
[ Wed, Sep 22nd 2010 ] - Market Wire
ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC P .. CIENTIFIC CORPORATION';S PLATINUM CHROMIUM TAXUS(
[ Wed, Sep 22nd 2010 ] - Market Wire
India Approves Advaxis Trial in Cervix Cancer
[ Wed, Sep 22nd 2010 ] - Market Wire
Cardiovascular Systems Reports Results from Three .. eripheral Clinical Studies at TCT on September 22
[ Wed, Sep 22nd 2010 ] - Market Wire
IMAGING DYNAMICS Completes Rights Offering
[ Wed, Sep 22nd 2010 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Fifth An .. ities Healthcare Conference on September 28, 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
Health Net Again Named to Hispanic Business Magazinea?s Diversity Elite Top 60
[ Wed, Sep 22nd 2010 ] - Market Wire
RXi Pharmaceuticals and EyeGate Pharma Announce C .. Non-Invasive Ocular Delivery of RNAi Therapeutics
[ Wed, Sep 22nd 2010 ] - Market Wire
HEALTH NET APARECE NUEVAMENTE EN EL TOP 60 DE LA .. DE LA DIVERSIDAD DE LA REVISTA HISPANIC BUSINESS
[ Wed, Sep 22nd 2010 ] - Market Wire
Edge Healthcare Partners, LLC Advises Gentiva Hea .. viously Announced Acquisition of Odyssey HealthCa
[ Wed, Sep 22nd 2010 ] - Market Wire
Valeant and Biovail Announce Valeanta?s Intention .. d to Valeant Stockholders upon Obtaining Sharehol
[ Wed, Sep 22nd 2010 ] - Market Wire
St. Jude Medical to Showcase New Lesion Assessment Technology at TCT 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
Medtronica?s Resolute Drug-Eluting Stent Shows Strong Performance in Second aAll Comersa? Study
[ Wed, Sep 22nd 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present at the JMP Healthcare Conference
[ Wed, Sep 22nd 2010 ] - Market Wire
Zalicus to Present at the Fifth Annual JMP Securities Healthcare Conference
[ Wed, Sep 22nd 2010 ] - Market Wire
Aeterna Zentaris to Present at Upcoming Sachs 10t .. l Biotech Europe Investment Forum on September 29
Tue, September 21, 2010
[ Tue, Sep 21st 2010 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Baxter International Inc.
[ Tue, Sep 21st 2010 ] - Market Wire
RehabCare Aligns Information Technology with Delivery of Care
[ Tue, Sep 21st 2010 ] - Market Wire
Chemed Corporation to Present at JMP Securities Healthcare Conference
[ Tue, Sep 21st 2010 ] - Market Wire
Response Genetics, Inc. Sets New Date for 2010 Annual Meeting of Stockholders
[ Tue, Sep 21st 2010 ] - Market Wire
DIAGNOCURE';S PCA3 PROSTATE CANCER BIOMARKER SUBM .. EN-PROBE TO THE U.S. FOOD AND DRUG ADMINISTRATION
[ Tue, Sep 21st 2010 ] - Market Wire
Apricus Bio Receives FDA Guidance on Phase 3 Stud .. t for Raynauda?s Syndrome, Secondary to Scleroder
[ Tue, Sep 21st 2010 ] - Market Wire
Teva Files Complaint against Mylan for Infringement of Four Copaxone®-Related Patents
[ Tue, Sep 21st 2010 ] - Market Wire
Biogen Idec Announces Webcast of Hemophilia R&D Roundtable

Biogen Idec Announces Webcast of Hemophilia R&D Roundtable


Published on 2010-09-21 09:00:55 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its Hemophilia R&D Roundtable will be webcast live on Tuesday, September 28, 2010 at 1:00 p.m. EDT. To access the live webcast, please visit Biogen Ideca™s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources